Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

GRISEOFULVIN 125 MG/5 ML SUSP

Griseofulvin (microsize)
$0.2617per ML

Strength

125 mg/5mL

Manufacturer

Chartwell RX LLC

NDC

62135096841

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

GRISEOFULVIN

Approval Type

Generic (ANDA)

FDA Application

ANDA065200

On Market Since

3/2/2005

Pharmacological Classes

Decreased Mitosis
Microtubule Inhibition
Tubulin Inhibiting Agent

Price History

1W

0.0%

1M

-1.6%

3M

-2.3%

6M

-5.1%

1Y

-11.8%

3Y

-36.2%

5Y

N/A

All

-0.8%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

GRISEOFULVIN 125 MG/5 ML SUSP
Generic
00472001304•Actavis Pharma, Inc.
$0.2617
per ML
GRISEOFULVIN 125 MG/5 ML SUSP
Generic
69097036108•Cipla USA Inc.
$0.2617
per ML
GRISEOFULVIN 125 MG/5 ML SUSP
Generic
00713085004•Cosette Pharmaceuticals, Inc.
$0.3348
per ML
PACLITAXEL 300 MG/50 ML VIAL
Generic
61703034250•Hospira Inc.
$1.7700
per ML
PACLITAXEL 300 MG/50 ML VIAL
Generic
63323076350•Fresenius Kabi USA, LLC
$1.7700
per ML
PACLITAXEL 100 MG/16.7 ML VIAL
Generic
61703034222•Hospira Inc.
$1.8891
per ML
PACLITAXEL 100 MG/16.7 ML VIAL
Generic
63323076316•Fresenius Kabi USA, LLC
$1.8891
per ML
PACLITAXEL 30 MG/5 ML VIAL
Generic
61703034209•Hospira Inc.
$2.1290
per ML
GRISEOFULVIN ULTRA 125 MG TAB
Generic
00115172401•Amneal Pharmaceuticals of New York LLC
$2.9646
per EA
GRISEOFULVIN ULTRA 125 MG TAB
Generic
00781582701•Sandoz Inc.
$2.9646
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy